PHARMACEUTICAL PRODUCT DEVELOPMENT INC Accounts Receivable, Credit Loss Expense (Reversal)
PHARMACEUTICAL PRODUCT DEVELOPMENT INC reported Accounts Receivable, Credit Loss Expense (Reversal) of $640.00 thousand for the 12-month period ending 2010-12-31, per its 10-K filed 2011-02-25.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2011-02-25
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC accounts receivable, credit loss expense (reversal) for fiscal 2010 was $640.00K, a 81.10% decline from fiscal 2009.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC accounts receivable, credit loss expense (reversal) for fiscal 2009 was $3.39M, a 64.25% decline from fiscal 2008.
- PHARMACEUTICAL PRODUCT DEVELOPMENT INC accounts receivable, credit loss expense (reversal) for fiscal 2008 was $9.47M.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|
| 2010-12-31 | $640.00K 10-K · filed 2011-02-25 |
| 2009-12-31 | $3.39M 10-K · filed 2011-02-25 |
| 2008-12-31 | $9.47M 10-K · filed 2011-02-25 |